Fatty airways: a source of good and bad fats?
- PMID: 31831675
- DOI: 10.1183/13993003.02060-2019
Fatty airways: a source of good and bad fats?
Conflict of interest statement
Conflict of interest: C.E. Brightling reports grants and personal fees for consultancy from AZ, GSK, Novartis, Chiesi, Gossamer, 4DPharma, BI and Mologic, grants from Merck and Genentech/Roche, and personal fees for consultancy from TEVA and Sanofi, outside the submitted work. Conflict of interest: A.B. Tobin has nothing to disclose. Conflict of interest: G. Milligan is director of Calden Therapeutics.
Comment on
-
Fatty airways: implications for obstructive disease.Eur Respir J. 2019 Dec 12;54(6):1900857. doi: 10.1183/13993003.00857-2019. Print 2019 Dec. Eur Respir J. 2019. PMID: 31624112
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials